United States · FDA National Drug Code directory
Venlafaxine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65862-404_426d12db-50e2-4915-999f-84645fb387d9
- Product NDC
- 65862-404
- Form
- TABLET
- Composition / generic term
- Venlafaxine Hydrochloride
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20100407
- Source listing expiry
- 20261231
Source-listed ingredients
- VENLAFAXINE HYDROCHLORIDE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (65862-404-01) · 65862-404-01
- 10 BLISTER PACK in 1 CARTON (65862-404-10) / 10 TABLET in 1 BLISTER PACK · 65862-404-10
- 30 TABLET in 1 BOTTLE (65862-404-30) · 65862-404-30
- 60 TABLET in 1 BOTTLE (65862-404-60) · 65862-404-60
- 7000 TABLET in 1 BOTTLE (65862-404-71) · 65862-404-71
- 90 TABLET in 1 BOTTLE (65862-404-90) · 65862-404-90
- 1000 TABLET in 1 BOTTLE (65862-404-99) · 65862-404-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →